G. Dimopoulos (Athens, Greece), A. Singanayagam (London, United Kingdom), A. Anzueto (San Antonio, United States of America), K. Rohmann (Luebeck, Germany)
Treatment of refractory mycobacterium avium complex lung disease with a moxifloxacin-containing regimen
G. Hong, S. Y. Kim, B. H. Jeong, H. Y. Park, K. Jeon, O. J. Kwon, S. H. Lee, C. K. Kim, S. J. Shin, W. J. Koh (Seoul, Chungbuk, Republic Of Korea)
|  |
Nebulised colistimethate sodium improves quality of life in patients with bronchiectasis colonised by pseudomonas aeruginosa
C. Haworth, D. Bilton, R. Kenyon (Cambridge, London, Chichester, United Kingdom)
|  |
Antibiotic resistance in ambulatory patients with chronic obstructive pulmonary disease–clinical signs
P. Nikolova, T. Popova, Z. Dikova, P. Pavlov, Y. Ivanov, N. Yanev, N. Kyuchukov, S. Pachkova (Pleven, Bulgaria)
| |
Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP)
H. Demchuk, Y. Mostovoy (Vinnytsia, Ukraine)
| |
Antimicrobial susceptibility of stenotrophomonas maltophilia isolated from respiratory specimens from a tertiary care center in Pakistan
K. Jabeen, J. Farooqi, M. Irfan, E. Khan, R. Hasan (Karachi, Pakistan)
| |
Influence of long antibiotic therapy of lower respiratory tract infection (LRTI) on cytological characteristics of sputum
A. Demchuk, H. Demchuk, Y. Mostovoy (Vinnytsia, Ukraine)
| |
Antibiotics therapy against airway’s infections during pregnancy and related problems
R. Bontsevich, O. Golovchenko, V. Kulikovsky, M. Pokrovsky, T. Pokrovskaya, Y. Afanasjev (Belgorod, Russian Federation)
| |
The adherence of Greek chest physicians to the 2007 IDSA/ATS and the Greek national guidelines for CAP
C. Triantafyllidis, V. Kapordelis, E. C. Filippidou, G. Papaetis, D. Orfanidou, M. Apostolidou, I. Nikolopoulos, A. Pefanis (Athens, Kavala, Greece)
| |
Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia
C. Rodrigo, T. Bewick, C. Sheppard, S. Greenwood, M. Slack, C. Trotter, R. George, W. S. Lim (Nottingham, Colindale, London, Bristol, United Kingdom)
| |
Antimicrobial profile and bacterial resistance in patients wit acute exacerbation of COPD, an Upper Egypt multicenters experience
Y. Gad, G. Agmy (Assuit, Egypt)
| |
Pneumococcal and influenza vaccine uptake in patients discharged from an acute medical hospital
S. Camilleri, M. Balzan, K. Yamagata, C. Zammit, R. Casha, J. Casingena Garcia (Tal Qroqq, Malta)
| |
Analysis of the patients with community acquired pneumonia treated in MHAT “St. Marina”, Varna, Bulgaria for the 2011–2012 period
V. Kostadinova, Y. Radkov, I. Mircheva (Varna, Bulgaria)
| |
A study of incidence, outcome and antibiotic sensitivity pattern of ventilator associated pneumonia in icu of tertiary care hospital in Nepal
D. R. Mishra (Dharan, Nepal)
| |
A study of antibiogram assay, risk factors and etiology of ventilator associated pneumonia (VAP) in a tertiary care hospital of Pakistan
T. Ijaz, S. Aslam, S. Raja, B. Ahmad, A. Anjum, S. Ijaz (Lahore, Pakistan)
| |
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia
Y. S. Kang, G. M. Park, J. Y. Oh, I. Jeong, Y. J. Jeong, Y. S. Yoon (Goyang, Seoul, Republic Of Korea)
| |
Factors associated with mortality in ventilator associated pneumonia of multidrug resistant acinetobacter baumannii
A. Sengul, E. Sengul, S. A. Baris, N. Hayirlioglu (Kocaeli, Turkey)
| |
Evaluation of nephrotoxicity due to the use of colistimethate sodium in a intensive care unit
M. E. Akkoyunlu, B. Ceylan, Y. Akkoyunlu, D. Özkan, H. Özçelik, T. Aslan, L. Kart (Istanbul, Turkey)
| |
Colistin therapy for nosocomial pneumonia and nephrotoxicity
P. Ekren, Z. N. Töreyin, A. çeltik, H. Pullukçu, A. Gürgün, H. Uluer, F. Bacakoglu, S. S. Aydemir, A. Sayiner (Izmir, Turkey)
| |
Penetration of moxifloxacin in bronchial secretions in hospitalized patients with acute exacerbation of COPD
M. Sionidou, G. Pitsiou, K. Manika, K. Chatzika, P. Kontou, K. Zarogoulidis, I. Kioumis (Thessaloniki, Greece)
| |